Enanta Pharmaceuticals (ENTA) Q2 2023 Earnings

7AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-2.33
-1.98
-1.62
-1.27

Details

Expected EPS
-2.33
Actual EPS
-1.86
Surprise EPS
0.47
Surprise Percent
+20.17%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -1.86 per share for Q2 2023.

0 Comments

Share your thoughts